Edoxaban Anticoagulation in Atrial Fibrillation: Real-World Data and Evidence

This article provides an overview of real-world evidence regarding edoxaban's use in preventing stroke and systemic embolic events in AF patients, emphasizing the concerns that physicians factor into their clinical decision-making.PMID:38164780 | DOI:10.5543/tkda.2023.73869

Source: Turk Kardiyoloji Dernegi arsivi - January 2, 2024 Category: Cardiology Authors: Serkan Çay Mithat Kasap Source Type: research